SHARE
Hydroxychloroquine Market

Hydroxychloroquine - Global Market Outlook (2018-2027)

4.8 (49 reviews)
Published: May 2020 ID: SMRC19127
4.8 (49 reviews)
Published: May 2020 ID: SMRC19127

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Hydroxychloroquine Market is accounted for $41.30 million in 2018 and is expected to reach $100.62 million by 2027 growing at a CAGR of 10.4% during the forecast period. The rising geriatric population, and the high demand for the drug from third world nations for dealing with malarial are the major factors propelling the market growth. However, factors such as product recalls and discontinuation of drugs are hampering the market growth.

Hydroxychloroquine is a medication and analogue of chloroquine. It has antirheumatic as well as antimalarial properties. It has been used widely for the treatment of infectious as well as rheumatoid arthritis. It has been recognized that clinical use of hydroxychloroquine has significantly improve the treatment rate of patient suffering from the COVID-19. The growth of hydroxychloroquine enhanced by the growing cases of infectious diseases that majorly includes coronavirus and malaria and increase research and development activities. In addition, advances in the treatment options and presence of well-established healthcare facilities are some of the impacting factors for the demand of hydroxychloroquine drugs.

Based on the application, the COVID-19 segment is going to have a lucrative growth during the forecast period as this is a new condition and a large number of trials are conducted on the effectiveness of the medicine in treating the condition, it would contribute to the growth rate witnessed by this segment. The fact that a large number of patients with COVID-19 are admitted to hospitals for treatment results in high preference and dependence on this medicine, contributing to the market share held by this segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period attributed to India being the leading producer of the drug and China being the largest exporter of the raw materials for the drug production. Apart from this, it is cost-effective drug in India costing nearly lesser than rupees three per tablet. Moreover, the drug has been advocated in countries like India as a measure to prevent the coronavirus in people who have been in contact with COVID positive persons and those falling in high risk zone. All these aforementioned aspects are likely to favorably leverage the growth of the Hydroxychloroquine market over the forecast period.
Some of the key players profiled in the Hydroxychloroquine Market include Hikma Pharmaceuticals PLC, Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG , Mylan N.V, Sanofi S.A, Taj Pharmaceuticals Ltd , Shanghai Pharmaceuticals Holding Co., Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd , Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, and Zydus Cadila.
Types Covered:
• Tablets
• Injection

Route of Administrations Covered:
• Oral
• Intravenous  

Grades Covered:
• United States Pharmacopeial Convention (USP) Standards Grade
• Pharmaceutical Standards Grade
• European Pharmacopoeia (EP) Standards Grade

Strengths Covered:
• 100 mg
• 200 mg
• 250 mg
• 400 mg
• 500 mg
• 800 mg

Distribution Channels Covered:
• Hospital Pharmacy
• Online Pharmacy
• Speciality Drug Stores
• Retail Pharmacy
• Homeocare

Applications Covered:
• Malaria
• Rheumatoid arthritis
• Lupus Erythematosus
• Skin Lesions
• COVID-19

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary             
               
2 Preface  
            
 2.1 Abstract             
 2.2 Stake Holders            
 2.3 Research Scope             
 2.4 Research Methodology           
  2.4.1 Data Mining           
  2.4.2 Data Analysis           
  2.4.3 Data Validation           
  2.4.4 Research Approach           
 2.5 Research Sources            
  2.5.1 Primary Research Sources           
  2.5.2 Secondary Research Sources          
  2.5.3 Assumptions           
               
3 Market Trend Analysis    
        
 3.1 Introduction            
 3.2 Drivers             
 3.3 Restraints            
 3.4 Opportunities             
 3.5 Threats             
 3.6 Application Analysis           
 3.7 Emerging Markets            
 3.8 Impact of Covid-19            
               
4 Porters Five Force Analysis            
 4.1 Bargaining power of suppliers           
 4.2 Bargaining power of buyers           
 4.3 Threat of substitutes           
 4.4 Threat of new entrants           
 4.5 Competitive rivalry            
               
5 Global Hydroxychloroquine Market, By Type          
 5.1 Introduction            
 5.2 Tablets             
 5.3 Injection             
               
6 Global Hydroxychloroquine Market, By Route of Administration        
 6.1 Introduction            
 6.2 Oral             
 6.3 Intravenous            
               
7 Global Hydroxychloroquine Market, By Grade          
 7.1 Introduction            
 7.2 United States Pharmacopeial Convention (USP) Standards Grade       
 7.3 Pharmaceutical Standards Grade          
 7.4 European Pharmacopoeia (EP) Standards Grade         
               
8 Global Hydroxychloroquine Market, By Strength          
 8.1 Introduction            
 8.2 100 mg             
 8.3 200 mg             
 8.4 250 mg             
 8.5 400 mg             
 8.6 500 mg             
 8.7 800 mg              
               
9 Global Hydroxychloroquine Market, By Distribution Channel     
     
 9.1 Introduction            
 9.2 Hospital Pharmacy            
 9.3 Online Pharmacy            
 9.4 Speciality Drug Stores           
 9.5 Retail Pharmacy            
 9.6 Homeocare            
               
10 Global Hydroxychloroquine Market, By Application       
   
 10.1 Introduction            
 10.2 Malaria             
 10.3 Rheumatoid arthritis           
 10.4 Lupus Erythematosus            
  10.4.1 Systemic Lupus Erythematosus         
  10.4.2 Chronic Discoid Lupus Erythematosus         
 10.5 Skin Lesions            
 10.6 COVID-19             
               
11 Global Hydroxychloroquine Market, By Geography          
 11.1 Introduction            
 11.2 North America            
  11.2.1 US            
  11.2.2 Canada            
  11.2.3 Mexico            
 11.3 Europe             
  11.3.1 Germany            
  11.3.2 UK            
  11.3.3 Italy            
  11.3.4 France            
  11.3.5 Spain            
  11.3.6 Rest of Europe           
 11.4 Asia Pacific            
  11.4.1 Japan            
  11.4.2 China            
  11.4.3 India            
  11.4.4 Australia            
  11.4.5 New Zealand            
  11.4.6 South Korea           
  11.4.7 Rest of Asia Pacific           
 11.5 South America            
  11.5.1 Argentina           
  11.5.2 Brazil            
  11.5.3 Chile            
  11.5.4 Rest of South America          
 11.6 Middle East & Africa           
  11.6.1 Saudi Arabia           
  11.6.2 UAE            
  11.6.3 Qatar            
  11.6.4 South Africa           
  11.6.5 Rest of Middle East & Africa          
               
12 Key Developments             
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures        
 12.2 Acquisitions & Mergers           
 12.3 New Product Launch           
 12.4 Expansions            
 12.5 Other Key Strategies           
               
13 Company Profiling              
 13.1 Hikma Pharmaceuticals PLC           
 13.2 Cadila Healthcare Ltd           
 13.3 Ipca Laboratories Ltd           
 13.4 Novartis AG            
 13.5 Mylan N.V            
 13.6 Sanofi S.A            
 13.7 Taj Pharmaceuticals Ltd           
 13.8 Shanghai Pharmaceuticals Holding Co., Ltd         
 13.9 Torrent Pharmaceuticals Ltd           
 13.10 Teva Pharmaceutical Industries Ltd          
 13.11 Dr. Reddy’s Laboratories Ltd           
 13.12 Sun Pharmaceutical Industries Ltd          
 13.13 Zydus Cadila           


List of Tables              
1 Global Hydroxychloroquine Market Outlook, By Region (2017-2027) ($MN)       
2 Global Hydroxychloroquine Market Outlook, By Type (2017-2027) ($MN)        
3 Global Hydroxychloroquine Market Outlook, By Tablets (2017-2027) ($MN)       
4 Global Hydroxychloroquine Market Outlook, By Injection (2017-2027) ($MN)       
5 Global Hydroxychloroquine Market Outlook, By Route of Administration (2017-2027) ($MN)       
6 Global Hydroxychloroquine Market Outlook, By Oral (2017-2027) ($MN)        
7 Global Hydroxychloroquine Market Outlook, By Intravenous (2017-2027) ($MN)       
8 Global Hydroxychloroquine Market Outlook, By Grade (2017-2027) ($MN)       
9 Global Hydroxychloroquine Market Outlook, By United States Pharmacopeial Convention (USP) Standards Grade (2017-2027) ($MN)  
10 Global Hydroxychloroquine Market Outlook, By Pharmaceutical Standards Grade (2017-2027) ($MN)     
11 Global Hydroxychloroquine Market Outlook, By European Pharmacopoeia (EP) Standards Grade (2017-2027) ($MN)   
12 Global Hydroxychloroquine Market Outlook, By Strength (2017-2027) ($MN)       
13 Global Hydroxychloroquine Market Outlook, By 100 mg (2017-2027) ($MN)       
14 Global Hydroxychloroquine Market Outlook, By 200 mg (2017-2027) ($MN)       
15 Global Hydroxychloroquine Market Outlook, By 250 mg (2017-2027) ($MN)       
16 Global Hydroxychloroquine Market Outlook, By 400 mg (2017-2027) ($MN)       
17 Global Hydroxychloroquine Market Outlook, By 500 mg (2017-2027) ($MN)       
18 Global Hydroxychloroquine Market Outlook, By 800 mg (2017-2027) ($MN)       
19 Global Hydroxychloroquine Market Outlook, By Distribution Channel (2017-2027) ($MN)      
20 Global Hydroxychloroquine Market Outlook, By Hospital Pharmacy (2017-2027) ($MN)      
21 Global Hydroxychloroquine Market Outlook, By Online Pharmacy (2017-2027) ($MN)      
22 Global Hydroxychloroquine Market Outlook, By Speciality Drug Stores (2017-2027) ($MN)      
23 Global Hydroxychloroquine Market Outlook, By Retail Pharmacy (2017-2027) ($MN)      
24 Global Hydroxychloroquine Market Outlook, By Homeocare (2017-2027) ($MN)       
25 Global Hydroxychloroquine Market Outlook, By Application (2017-2027) ($MN)       
26 Global Hydroxychloroquine Market Outlook, By Malaria (2017-2027) ($MN)       
27 Global Hydroxychloroquine Market Outlook, By Rheumatoid arthritis (2017-2027) ($MN)      
28 Global Hydroxychloroquine Market Outlook, By Lupus Erythematosus (2017-2027) ($MN)      
29 Global Hydroxychloroquine Market Outlook, By Systemic Lupus Erythematosus (2017-2027) ($MN)     
30 Global Hydroxychloroquine Market Outlook, By Chronic Discoid Lupus Erythematosus (2017-2027) ($MN)    
31 Global Hydroxychloroquine Market Outlook, By Skin Lesions (2017-2027) ($MN)       
32 Global Hydroxychloroquine Market Outlook, By COVID-19 (2017-2027) ($MN)       
               
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above. 

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials